Stevanato Group S.p.A. Profile Avatar - Palmy Investing

Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, …
Medical - Instruments & Supplies
IT, Piombino Dese [HQ]

Balance Sheet

5 Sheets · Starting from 2023
In Million EUR. Margins, Growth Rates In %
Metric 2019 2020 2021 2022 2023
Assets
882.00 967.00 1,418.00 1,659.00 2,073.00
Current
449.00 492.00 865.00 845.00 862.00
Non Current
432.00 475.00 552.00 811.00 1,210.00
Liabilities
616.00 657.00 577.00 663.00 939.00
Current
262.00 316.00 338.00 462.00 574.00
Non Current
353.00 341.00 36.00 52.00 364.00
Equity
265.00 310.00 841.00 995.00 1,133.00
Stockholders' Equity
265.00 310.00 841.00 995.00 1,133.00
Retained Earnings
287.00 355.00 27.00 26.00 757.00
Common Stock
20.00 20.00 21.00 21.00 21.00
Preferred Stock
- - - - - - - - - -
Profit
39.00 78.00 134.00 142.00 145.00
Dividends
-6.00 -8.00 -11.00 -13.00 -14.00
Minority Interest
- - - - - - - - - -
Other Stockholders' Equity
-248.00 -277.00 106.00 116.00 -395.00
Loss Other Compr. Income
206.00 211.00 686.00 831.00 749.00
End of STVN's Analysis
CIK: 1849853 CUSIP: T9224W109 ISIN: IT0005452658 LEI: - UEI: -
Secondary Listings
STVN has no secondary listings inside our databases.